Westgold Resources Ltd (WGX)
Australian Securities Exchange · Australia · prices in AUD · close of 19 Oct 2026
Key indicators
| Last close | AUD 5.010 |
|---|---|
| 52-week range | 4.165 – 8.015 |
| Return, 1 month / 3 months | −9.4% / +5.2% |
| Return, 1 year / 3 years | −9.7% / +155.5% |
| Trend | Below its 200-day average |
| RSI (14) | 40 |
| Volatility (1 year) | 55.2% |
| Worst drawdown (1 year) | -46.0% |
| Average daily value traded | 21.66M AUD |
| Dividend yield | 2.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Westgold Resources is an Australian gold mining company that explores for, develops and operates gold projects in Western Australia. It runs underground and open pit mines and processes ore at its own treatment plants, producing gold doré that is refined and sold to precious metals markets. The company is based in Perth and focuses its activities on established mining regions of Western Australia, where it manages exploration, mining and processing across its portfolio of operations.
On this site Westgold Resources Ltd appears as a stock on the Australian Securities Exchange (Australia), code WGX, with prices in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Westgold Resources Ltd (WGX) trades on the Australian Securities Exchange in Australia. It last closed at AUD 5.010 on 19 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 621 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 9.7% and over the last three months it rose 5.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 57 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -12.8% | ||
| From 52-week high | -36.6% | ||
| Momentum | 61 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 5.2% | ||
| 6-month return | -17.6% | ||
| 12-month return, skipping the last month | -0.4% | ||
| Stability (higher is calmer) | 65 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 55.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -46.0% | ||
| Liquidity | 95 · Strong | Trades actively. | |
| Average daily value traded | 21.66M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 15 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.0% | ||
| Years with dividends | 3 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −3.8% |
|---|---|
| 1 month | −9.4% |
| 3 months | +5.2% |
| 6 months | −17.6% |
| 1 year | −9.7% |
| 3 years | +155.5% |
| 5 years | +156.8% |
Signals
| 50-day / 200-day average | 5.663 / 5.745 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.187 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Sep 2026 | AUD 0.1000 |
| 11 Sep 2025 | AUD 0.0300 |
| 11 Jul 2024 | AUD 0.0125 |
| 28 Mar 2024 | AUD 0.0100 |
| 30 Sep 2021 | AUD 0.0200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.